AstraZeneca strikes $6bn worth deal for Daiichi Sankyo’s DS-1062
AstraZeneca has signed a deal potentially worth up to $6 billion with Daiichi Sankyo for the global development and commercialization for the latter’s DS-1062, a trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC), which is being developed for the treatment of multiple tumor types. Daiichi Sankyo is developing the antibody drug conjugate for multiple tumors […]
Qinlock FDA approval : Deciphera Pharmaceuticals has been granted approval from the US Food and Drug Administration (FDA) for Qinlock (ripretinib) in advanced gastrointestinal stromal tumor (GIST) in adult patients who had prior treatment with three or more kinase inhibitors, including imatinib. The decision from the FDA marks Qinlock as the first drug approved in […]
Continue reading …
A research team headed by Hong Kong Baptist University (HKBU) claims to have developed a novel anti-Epstein-Barr virus (EBV) drug for the treatment of nasopharyngeal cancer and other EBV-related cancers. The novel anti-viral targeted drug can disrupt a viral protein produced by EBV selectively, thereby resulting in shrinkage of tumors caused by the human herpesvirus […]
Continue reading …Selpercatinib FDA approval : Lilly’s therapy approved for treatment of lung and thyroid cancers with RET alteration
May 9, 2020 No Comment
Selpercatinib FDA approval : The US Food and Drug Administration (FDA) has approved Eli Lilly and Company’s Retevmo (selpercatinib) capsules for the treatment of three types of tumors – non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancers. The approvals are for the drug to be used in patients whose tumors […]
Continue reading …
US biopharma company Amgen has signed an all-cash deal to acquire a 20.5% stake in Chinese biotech company BeiGene for about $2.7 billion, as per the latest pharma acquisition news. The Beijing-based BeiGene is a research-based, oncology-focused biotechnology company, which is engaged in developing molecularly targeted and immuno-oncology drug candidates for cancer treatment. The transaction […]
Continue reading …
Cancer cells have special characteristics than the normal cells and you can know what are the special characteristics of the cancer cells below. The special characteristics of cancer cells are: Uncontrolled proliferation Apoptosis and genesis of a cancer cell Expression of Telomerases Control of tumor related blood vessels Dedifferentiation and loss of function Invasiveness Metastases […]
Continue reading …
What is meant by metastasis? Metastasis is the ability of the tumor cells to spread to other parts of the body and establish secondary tumors. Malignant tumors break loose from the mass and spread to other parts of the body through lymphatic system and blood stream. Extra cellular matrix will be present between the surrounding […]
Continue reading …
What is meant by Cancer? Cancer is a large, heterogenous class of diseases, characterized by uncontrolled growth of cells that invade the surrounding tissues and destroys them. In simple terms, cancer is a disease that results from the abnormal growth and differentiation of the tissues. What are the synonyms of Cancer? The synonyms of cancer […]
Continue reading …
Business News Today
- MedCrypt acquires medical device cybersecurity software firm MedISAO
- Improving acquires custom software development firm Object Partners
- High Street Insurance acquires Michigan-based Capital Insurance Group
- Mill Creek Residential breaks ground on Modera Washington in Houston
- Cincinnati-based RIA Lenox Wealth Management acquired by Creative Planning
- Jersey Elevator acquired by Arcline Investment Management
- U.S. Gold acquires Northern Panther Resource, owner of Challis gold project
- Perrigo acquires skincare and hair loss treatment brands from Sanofi
- Bayer to acquire KaNDy Therapeutics to add menopause drug candidate
- Thoma Bravo to acquire US insurtech Majesco for higher price of $729m
